ZnO Nanoparticles as Potent Inducers of Dermal Immunosuppression in Contact Hypersensitivity in Mice.

RSEQ chemotaxis contact hypersensitivity (CHS) inflammation metal oxide nanoparticles mouse model

Journal

ACS nano
ISSN: 1936-086X
Titre abrégé: ACS Nano
Pays: United States
ID NLM: 101313589

Informations de publication

Date de publication:
14 Oct 2024
Historique:
medline: 14 10 2024
pubmed: 14 10 2024
entrez: 14 10 2024
Statut: aheadofprint

Résumé

Nanosized zinc oxide (nZnO) metal particles are used in skin creams and sunscreens to enhance their texture and optical properties as UV filters. Despite their common use, little is known about the molecular mechanisms of nZnO exposure on damaged skin. We studied the effects of topically applied nZnO particles on allergic skin inflammation in an oxazolone (OXA)-induced contact hypersensitivity (CHS) mouse model. We investigated whether exposure to nZnO during the sensitization or challenge phase would induce immunological changes and modulate transcriptional responses. We followed skin thickness, cellular infiltration, and changes in the local transcriptome up to 28 days after the challenge. The responses peaked at 24 h and were fully resolved by 28 days. Co-exposure to nZnO and hapten did not interfere with the formation of the sensitization process. Conversely, during the hapten challenge, the application of nZnO fully suppressed the development of the CHS response by the inhibition of pro-inflammatory pathways, secretion of pro-inflammatory cytokines, and proliferation of immune cells. In differentiated and stimulated THP-1 cells and the CHS mouse model, we found that nZnO particles and Zn ions contributed to anti-inflammatory responses. The immunosuppressive properties of nZnO in inflamed skin are mediated by impaired IL-1R-, CXCR2-, and LTB4-mediated pathways. nZnO-induced dermal immunosuppression may be beneficial for individuals with contact allergies who use nZnO-containing cosmetic products. Our findings also provide a deeper understanding of the mechanisms of nZnO, which could be considered when developing nanoparticle-containing skin products.

Identifiants

pubmed: 39401296
doi: 10.1021/acsnano.4c04270
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Shuyuan Wang (S)

School of Biological Sciences, University of Hong Kong, Pok Fu Lam Road, 999077 Hong Kong, People's Republic of China.
Human Microbiome Research Program, University of Helsinki, Haartmaninkatu 3, 00290 Helsinki, Finland.

Marit Ilves (M)

Human Microbiome Research Program, University of Helsinki, Haartmaninkatu 3, 00290 Helsinki, Finland.

Kuunsäde Mäenpää (K)

Human Microbiome Research Program, University of Helsinki, Haartmaninkatu 3, 00290 Helsinki, Finland.

Lan Zhao (L)

Human Microbiome Research Program, University of Helsinki, Haartmaninkatu 3, 00290 Helsinki, Finland.

Hani El-Nezami (H)

School of Biological Sciences, University of Hong Kong, Pok Fu Lam Road, 999077 Hong Kong, People's Republic of China.
School of Medicine, Institute of Public Health and Clinical Nutrition, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland.

Piia Karisola (P)

Human Microbiome Research Program, University of Helsinki, Haartmaninkatu 3, 00290 Helsinki, Finland.

Harri Alenius (H)

Human Microbiome Research Program, University of Helsinki, Haartmaninkatu 3, 00290 Helsinki, Finland.
Institute of Environmental Medicine (IMM), Karolinska Institutet, 171 77 Stockholm, Sweden.

Classifications MeSH